Pharmaceutical Rapid Microbiology Testing Market | Key Players are Abbott Laboratories Inc., Alere Inc, Bio-Rad Laboratories, Danaher Corporation, Siemens Healthcare, etc.

According to the latest report published by Acute Market Reports, Inc., the market for rapid pharmaceutical microbiology testing was valued at USD 3.4 billion in 2015 and is expected to reach USD 6.2 billion by 2022, increasing to CAGR by 7.3 per cent from 2016 to 2022.

Market Insights

Rapid microbiological tests are gaining momentum on the global market as a reliable and cost-effective method for tracking and monitoring all types of microorganisms in pharmaceutical applications and other industrial settings. In addition, rapid microbiology tests offer faster and more accurate methods to help in the rapid detection of microbes and early diagnosis, saving costs and inventory. North America held the largest regional market, accounting for a market share of more than 36% in 2015, and is expected to dominate the global market for rapid microbiology tests in the 2016-2022 forecast period.

Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/pharmaceutical-rapid-microbiology-testing-market

A large number of market-oriented players providing a wider range of product portfolios are key to the growth of the North American region. Asia Pacific is expected to grow at the highest growth rate during the focus period, due to an increase in the number of laboratories in these regions and an increase in the gradation of existing laboratories for the automation of various instrumentation systems. Moreover, the market is wide open to the advancement of rapid diagnostic technologies to improve the turnaround time of the tests compared to conventional microbiology testing methods.

Among the technology types, the nucleic acid amplification technique had the largest share of rapid microbiology tests on the pharmaceutical industry market due to its low cost and high efficacy. Moreover, extensive applications of nucleic acid amplification testing would further fuel market growth in the coming years. Growth-based detection technologies are expected to grow at the highest growth rate during the forecast period due to their faster turnaround time and accuracy in microbe detection.

Due to its wide application in the final drug product and other applications, the sterility testing application had the largest share in the global rapid microbiology tests on the pharmaceutical market. Process water testing is expected to see the highest growth in the global market for rapid microbiology tests in the pharmaceutical industry during the 2016-2022 forecast period.

Some key participants of the global rapid pharmaceutical microbiology testing market are Hoffmann-La Roche Ltd., Quidel Corporation, Thermo-Fisher Scientific Inc., Bio-Rad Laboratories, Gen-Probe Inc., Siemens Healthcare Diagnostics Inc., Becton, Dickinson and Company, Sysmex Corporation, and Abbott Laboratories, among others.

Report Scope by Segments

By End User Type

• Raw material testing
• In-process testing
• Microbial limit testing
• Bioburden assessment
• Process water testing
• Environmental monitoring
• Sterility testing

By Technology Type

• Immunology based Methods
• Nucleic acid based amplification tests
  • Polymerase Chain Reaction
  • Nucleic Acid Sequence-based amplification (NASBA)
  • Others
• Mass Spectrometry based Methods
• Flow Cytometry based Methods
• Growth-based detection technologies
  • ATP-bioluminescence
  • Colorimeter detection
  • Autofluorescence detection
• Biochemical Tests

By Geography Segment

• North America (U.S., Rest of North America)
• Europe (U.K., Germany, France, Rest of Europe)
• Asia Pacific (China, Japan, India, Rest of Asia Pacific)
• Rest of the World (Middle East & Africa, Latin America)